Clinical Trial

Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)

Study acronym: SMOM
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone \[LH\], pregnanediol glucuronide \[PDG\], and basal body temperature \[BBT\]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, perform urine tests, upload test strip photos to the Premom App, and measure BBT. Both participant readings and AI-assisted app readings will be analyzed. The main goal is to find which marker pairings give the most accurate picture of ovulation timing and luteal phase length. Secondary goals include understanding ease of use, the number of tests required, and whether the app improves accuracy.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-07-28
minor Completion pushed: 2026-11-15 -> 2026-12-15 2026-07-28
Trial Details
NCT Number NCT07248046
Lead Sponsor Bruyère Health Research Institute.
Conditions Fertility, Mobile Applications, Artifical Intelligence, Cervical Mucus, Body Temperature, Luteinizing Hormone (LH), Ovulation, Menstrual Cycle +1 more
Enrollment 30 participants
Start Date 2026-01-15
Primary Completion 2026-09-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-27